ラス腫瘍遺伝子は,NIH 3T3細胞の電離放射線に対する固有の抵抗性を高めます
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor 48109.
まとめ
ラス・オンコゲンは,哺乳類の細胞の電離放射線に対する耐性を著しく高めます. この放射線抵抗性の増加は,単に細胞の変容ではなく,特定のラスの遺伝子変異の直接的な結果である.
科学分野:
- 分子生物学は分子生物学である.
- 放射生物学の放射生物学について
- 腫瘍学 腫瘍学
背景:
- 放射線損傷修復の細胞メカニズムを理解することは極めて重要です.
- 哺乳類の細胞は,電離放射線に対処する固有のメカニズムを持っています.
- 腫瘍遺伝子は,ストレス反応を含む細胞プロセスに役割を果たします.
研究 の 目的:
- 細胞放射線耐性におけるras腫瘍遺伝子の役割を調査する.
- ras遺伝子変異が放射線抵抗に特異的に影響するかどうかを判断する.
- 変形した細胞における放射線生存の強化の分子基礎を解明する.
主な方法:
- NIH 3T3細胞の活性化されたRAS腫瘍遺伝子による変異.
- 放射生物学的測定を用いた内在的放射線抵抗 (D0) の測定.
- ラス突然変異の効果と変異の効果を区別するために,リバータント細胞系を分析する.
主要な成果:
- 活性化されたras腫瘍遺伝子の変換により,NIH 3T3細胞の固有放射線抵抗 (D0) が著しく増加しました.
- この強化された放射線抵抗は,ras遺伝子の変異に直接関係していた.
- 機能的なras遺伝子を保持しているが,変換が欠けているリバータント細胞も,D0.0の増加を示した.
結論:
- 特定のras遺伝子変異は,細胞の放射線抵抗を大幅に増加させます.
- ラス・オンコゲンは,電離放射線に対する細胞応答の重要な調節体である.
- ras経路をターゲットにすることで,治療的な文脈で放射線感受性を修正するための戦略を提供することができます.
関連する概念動画
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:


